199 related articles for article (PubMed ID: 27328915)
21. YY1-induced long non-coding RNA PSMA3 antisense RNA 1 functions as a competing endogenous RNA for microRNA 214-5p to expedite the viability and restrict the apoptosis of bladder cancer cells via regulating programmed cell death-ligand 1.
Zhang M; Xu Y; Yin S; Qiu F
Bioengineered; 2021 Dec; 12(2):9150-9161. PubMed ID: 34720049
[TBL] [Abstract][Full Text] [Related]
22. LncRNA MAFG-AS1 Promotes the Progression of Bladder Cancer by Targeting the miR-143-3p/COX-2 Axis.
Li D; Zhong S; Zhu Z; Jiang X; Zhang J; Gu J; Chen F
Pathobiology; 2020; 87(6):345-355. PubMed ID: 33238264
[TBL] [Abstract][Full Text] [Related]
23. HOXD-AS1 facilitates cell migration and invasion as an oncogenic lncRNA by competitively binding to miR-877-3p and upregulating FGF2 in human cervical cancer.
Chen S; Li K
BMC Cancer; 2020 Sep; 20(1):924. PubMed ID: 32977766
[TBL] [Abstract][Full Text] [Related]
24. lncRNA HOXD-AS1 Regulates Proliferation and Chemo-Resistance of Castration-Resistant Prostate Cancer via Recruiting WDR5.
Gu P; Chen X; Xie R; Han J; Xie W; Wang B; Dong W; Chen C; Yang M; Jiang J; Chen Z; Huang J; Lin T
Mol Ther; 2017 Aug; 25(8):1959-1973. PubMed ID: 28487115
[TBL] [Abstract][Full Text] [Related]
25. HOXD-AS1 is a novel lncRNA encoded in HOXD cluster and a marker of neuroblastoma progression revealed via integrative analysis of noncoding transcriptome.
Yarmishyn AA; Batagov AO; Tan JZ; Sundaram GM; Sampath P; Kuznetsov VA; Kurochkin IV
BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S7. PubMed ID: 25522241
[TBL] [Abstract][Full Text] [Related]
26. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
[TBL] [Abstract][Full Text] [Related]
27. HOXD-AS1/miR-130a sponge regulates glioma development by targeting E2F8.
Chen Y; Zhao F; Cui D; Jiang R; Chen J; Huang Q; Shi J
Int J Cancer; 2018 Jun; 142(11):2313-2322. PubMed ID: 29341117
[TBL] [Abstract][Full Text] [Related]
28. HOXD-AS1 confers cisplatin resistance in gastric cancer through epigenetically silencing PDCD4 via recruiting EZH2.
Ye Y; Yang S; Han Y; Sun J; Xv L; Wu L; Ming L
Open Biol; 2019 Sep; 9(9):190068. PubMed ID: 31551012
[TBL] [Abstract][Full Text] [Related]
29. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
30. LncRNA HOXD-AS1 promotes epithelial ovarian cancer cells proliferation and invasion by targeting miR-133a-3p and activating Wnt/β-catenin signaling pathway.
Zhang Y; Dun Y; Zhou S; Huang XH
Biomed Pharmacother; 2017 Dec; 96():1216-1221. PubMed ID: 29239819
[TBL] [Abstract][Full Text] [Related]
31. Long noncoding RNA ABHD11-AS1 predicts the prognosis of pancreatic cancer patients and serves as a promoter by activating the PI3K-AKT pathway.
Qiao X; Lv SX; Qiao Y; Li QP; Ye B; Wang CC; Miao L
Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8630-8639. PubMed ID: 30575903
[TBL] [Abstract][Full Text] [Related]
32. Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.
Lin J; Zhan Y; Liu Y; Chen Z; Liang J; Li W; He A; Zhou L; Mei H; Wang F; Huang W
Oncotarget; 2017 Apr; 8(15):24202-24212. PubMed ID: 28445936
[TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA DLX6-AS1 facilitates bladder cancer progression through modulating miR-195-5p/VEGFA signaling pathway.
Wang H; Niu X; Jiang H; Mao F; Zhong B; Jiang X; Fu G
Aging (Albany NY); 2020 Aug; 12(16):16021-16034. PubMed ID: 32756011
[TBL] [Abstract][Full Text] [Related]
34. Increased lncRNA ABHD11-AS1 represses the malignant phenotypes of bladder cancer.
Chen M; Li J; Zhuang C; Cai Z
Oncotarget; 2017 Apr; 8(17):28176-28186. PubMed ID: 28157695
[TBL] [Abstract][Full Text] [Related]
35. Upregulation of the long non-coding RNA AFAP1-AS1 affects the proliferation, invasion and survival of tongue squamous cell carcinoma via the Wnt/β-catenin signaling pathway.
Wang ZY; Hu M; Dai MH; Xiong J; Zhang S; Wu HJ; Zhang SS; Gong ZJ
Mol Cancer; 2018 Jan; 17(1):3. PubMed ID: 29310682
[TBL] [Abstract][Full Text] [Related]
36. The noncoding RNA HOXD-AS1 is a critical regulator of the metastasis and apoptosis phenotype in human hepatocellular carcinoma.
Lu S; Zhou J; Sun Y; Li N; Miao M; Jiao B; Chen H
Mol Cancer; 2017 Jul; 16(1):125. PubMed ID: 28724429
[TBL] [Abstract][Full Text] [Related]
37. Long noncoding RNA HOXD-AS1 aggravates osteosarcoma carcinogenesis through epigenetically inhibiting p57 via EZH2.
Gu W; Zhang E; Song L; Tu L; Wang Z; Tian F; Aikenmu K; Chu G; Zhao J
Biomed Pharmacother; 2018 Oct; 106():890-895. PubMed ID: 30119259
[TBL] [Abstract][Full Text] [Related]
38. Long noncoding RNA HOXD-AS1 promotes the progression of pancreatic cancer through miR-664b-3p/PLAC8 axis.
Chen L; Niu W; Zhu D; Shao W; Qian Y
Pathol Res Pract; 2022 Apr; 232():153836. PubMed ID: 35279480
[TBL] [Abstract][Full Text] [Related]
39. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer.
Zheng W; Tian X; Cai L; Shen YM; Cao QS; Yang JY; Tian GY
Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10443-10452. PubMed ID: 31841198
[TBL] [Abstract][Full Text] [Related]
40. LncRNA ZNF503-AS1 acts as a tumor suppressor in bladder cancer by up-regulating Ca
He H; Wu S; Ai K; Xu R; Zhong Z; Wang Y; Zhang L; Zhao X; Zhu X
Cell Oncol (Dordr); 2021 Feb; 44(1):219-233. PubMed ID: 33001357
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
